ARCHIVES

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

More RFPs Coming On X-Ray imaging For Early Diagnosis, Including Sound

August 23, 1974

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005

Waksal To Pay Back $800,000 In Profits From Stock Sales

March 14, 2003

Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA

May 23, 1986

Pathology In Operating Suite Cuts Need for More Surgery

February 24, 2012

Cooperative Groups Fight Back: Members Seek Move To Multidisciplinary Approach, More Funds

May 30, 1975